Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon

References

• Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?. Comp Immunol Microbiol Infect Dis 2004; 27: 319–330
   PubMed Web of Science ®Google Scholar
• Guzmán MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003; 27: 1–13
   PubMed Web of Science ®Google Scholar
• Guzmán MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2: 33–42
   PubMed Web of Science ®Google Scholar
• surveillance. PAHODengue, Available from: http://www.paho.org/English/AD/DPC/CD/dengue.htm (Accessed 15 February 2006)
   Google Scholar
• Siqueira Jr JB, Martelli CMT, Coelho GE, Simplício ACR, Hatch DL. Dengue and dengue hemorrhagic fever, Brazil, 1981–2002. Emerg Infect Dis 2005; 11: 48–53
   PubMedGoogle Scholar
• Figueiredo RMP, Thatcher BD, Lima ML, Almeida TC, Alecrim WD, Guerra MVF. Exanthematous diseases and the first epidemic of dengue to occur in Manaus, Amazonas State, Brazil, during 1998–1999. Rev Soc Bras Med Trop 2004; 37: 476–479
   PubMedGoogle Scholar
• Mourão MPG, Lacerda MVG, Albuquerque BC, Sandoval JC, Figueiredo RMP, Pinto R, et al. Outbreak of dengue hemorrhagic fever in Manaus. Strategies of health assistance and outcome. 2001, Braz J Infect Dis ;5(Suppl. 2):S22
   Google Scholar
• Halstead SB. Dengue. Curr Opin Infect Dis 2002; 15: 471–476
   PubMedGoogle Scholar
• Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol 2000; 13: 261–276
   PubMed Web of Science ®Google Scholar
• Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep 2005; 4: 145–148
   PubMedGoogle Scholar
• Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998; 161: 6338–6346
   PubMed Web of Science ®Google Scholar
• Yang KD, Wang CL, Shaio MF. Production of cytokines and platelet activating factor in secondary dengue virus infections. J Infect Dis 1995; 72: 604–605
   Google Scholar
• Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol 2003; 71: 259–264
   PubMedGoogle Scholar
• Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001; 65: 840–847
   PubMed Web of Science ®Google Scholar
• Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179: 755–762
   PubMed Web of Science ®Google Scholar
• Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26(5 Pt 1)975–984
   PubMed Web of Science ®Google Scholar
• Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, Robles AM, et al. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 2004; 138: 299–303
   PubMed Web of Science ®Google Scholar
• Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 2001; 63: 143–149
   PubMed Web of Science ®Google Scholar
• Lin SF, Liu HW, Chang CS, Yen JH, Chen TP. Hematological aspects of dengue fever. Gaoxiong Yi Xue Ke Xue Za Zhi 1989; 5: 12–16
   PubMedGoogle Scholar
• Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H, Brandjes DP, Van Gorp EC. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003; 3: 33–41
   PubMedGoogle Scholar
• Srichaikul T, Nimmannitya S, Sripaisarn T, Kamolsilpa M, Pulgate C. Platelet function during the acute phase of dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1989; 20: 19–25
   PubMedGoogle Scholar
• Martinez-Torres E. Dengue and hemorrhagic dengue: The clinical aspects, Salud Publica Mex 1995;37(Suppl):S29–44
   Google Scholar
• World Health Organization (WHO). Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control 2nd ed. Publisher, Geneva 1997
   Google Scholar
• de Paula SO, Fonseca BA. Dengue: A review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004; 8: 390–398
   PubMedGoogle Scholar
• Wiwanitkit V. Bleeding and other presentations in Thai patients with dengue infection. Clin Appl Thromb Hemost 2004; 10: 397–398
   PubMedGoogle Scholar
• Narayanan M, Aravind MA, Thilothammal N, Prema R, Sargunam CS, Ramamurty N. Dengue fever epidemic in Chennai-a study of clinical profile and outcome. Indian Pediatr 2002; 39: 1027–1033
   PubMedGoogle Scholar
• Wiwanitkit V, Manusvanich P. Can hematocrit and platelet determination on admission predict shock in hospitalized children with dengue hemorrhagic fever? A clinical observation from a small outbreak. Clin Appl Thromb Hemost 2004; 10: 65–67
   PubMedGoogle Scholar
• Lum LC, Goh AY, Chan PW, El-Amin AL, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002; 140: 629–631
   PubMed Web of Science ®Google Scholar
• Gomber S, Ramachandran VG, Kumar S, Agarwal KN, Gupta P, Dewan DK. Hematological observations as diagnostic markers in dengue hemorrhagic fever-a reappraisal. Indian Pediatr 2001; 38: 477–481
   PubMedGoogle Scholar
• Méndez A, González G. Dengue haemorrhagic fever in children: Ten years of clinical experience. Biomédica 2003; 23: 180–193
   PubMedGoogle Scholar
• Montenegro D, Lacerda HR, Lira TM, Oliveira DS, Lima AA, Guimaraes MJ, Vasconcelos PG. Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002. Rev Soc Bras Med Trop 2006; 39: 9–13
   PubMedGoogle Scholar
• Witayathawornwong P. DHF in infants, late infants and older children: A comparative study. Southeast Asian J Trop Med Public Health 2005; 36: 896–900
   PubMedGoogle Scholar
• Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Complications associated to severe thrombocytopenia in patients with dengue. Rev Med Chil 2006; 134: 167–173
   PubMedGoogle Scholar
• Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 2004; 9: 1022–1029
   PubMed Web of Science ®Google Scholar
• Diaz-Quijano FA, Martinez-Vega RA, Villar-Centeno LA. Early indicators of severity in dengue virus infection. Enferm Infecc Microbiol Clin 2005; 23: 529–532
   PubMedGoogle Scholar
• Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995; 213: 254–257
   PubMed Web of Science ®Google Scholar
• Huang KJ, Li SY, Chen SC, Liu HS, Lin YS, Yeh TM, et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol 2000; 81(Pt 9)2177–2182
   PubMedGoogle Scholar
• Krishnamurti C, Peat RA, Cutting MA, Rothwell SW. Platelet adhesion to dengue-2 virus-infected endothelial cells. Am J Trop Med Hyg 2002; 66: 435–441
   PubMed Web of Science ®Google Scholar
• Halstead SB. Dengue: Hematologic aspects. Semin Hematol 1982; 19: 116–131
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. The tourniquet test is still a good screening tool for dengue illness. Trop Doct 2005; 35: 127–128
   PubMedGoogle Scholar
• Norlijah O, Khamisah AN, Kamarul A, Paeds M, Mangalam S. Repeated tourniquet testing as a diagnostic tool in dengue infection. Med J Malaysia 2006; 61: 22–27
   PubMedGoogle Scholar
• Halstead SB. More dengue, more questions. Emerg Infect Dis 2005; 11: 740–741
   PubMed Web of Science ®Google Scholar
• Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful?. Am J Trop Med Hyg 2004; 70: 172–179
   PubMed Web of Science ®Google Scholar
• Wali JP, Biswas A, Aggarwal P, Wig N, Handa R. Validity of tourniquet test in dengue haemorrhagic fever. J Assoc Physicians India 1999; 47: 203–204
   PubMedGoogle Scholar
• Shivbalan S, Anandnathan K, Balasubramanian S, Datta M, Amalraj E. Predictors of spontaneous bleeding in Dengue. Indian J Pediatr 2004; 71: 33–36
   PubMedGoogle Scholar
• Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J Trop Pediatr 2004; 50: 301–305
   PubMed Web of Science ®Google Scholar
• Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: Analysis of 1,585 cases. Braz J Infect Dis 2004; 8: 156–163
   PubMedGoogle Scholar
• Wiwanitkit V. Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection. Clin Appl Thromb Hemost 2005; 11: 112
   PubMedGoogle Scholar
• Kumar ND, Tomar V, Singh B, Kela K. Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol 2000; 43: 55–60
   PubMedGoogle Scholar
• Lum LC, Abdel-Latif Mel A, Goh AY, Chan PW, Lam SK. Preventive transfusion in Dengue shock syndrome-is it necessary?. J Pediatr 2003; 143: 682–684
   PubMed Web of Science ®Google Scholar
• Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000; 31: 10–14
   PubMedGoogle Scholar